B. Y. Ashwin

Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman–Moore strain) manufactured in India

P. Patel, R. Holla, Gangaboraiah, 2014, Human vaccines & immunotherapeutics.

Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis

S. Madhusudana, M. Sudarshan, M. Shamanna, 2014, Human vaccines & immunotherapeutics.

Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India

D. H. Narayana, R. Holla, S. Madhusudana, 2012, Human Vaccines & Immunotherapeutics.

Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: Results of In vitro and In vivo studies

S. Sudarshan, S. Madhusudana, B. Y. Ashwin, 2013, Human vaccines & immunotherapeutics.